Although antimicrobial resistance has been a known and growing problem for decades, only one new class of antibiotics has been discovered since 1984. Tackling AMR requires a fundamental change in how new antibiotics are valued, and government incentives that reward biotech firms for successfully developing them.

 

 

PFahroni/iStock

Read more…